New cancer clinical trial: A Multicenter Real World Study of Kanglaite for Cancer Cachexia

Published on: August 15, 2018 at 12:00PM
Condition:   Cancer Cachexia
Intervention:   Drug: Kanglaite Injection/Capsules
Sponsors:   Zhejiang Kanglaite Pharmaceutical Co.Ltd;   NanJing PLA 81 Hospital;   LinkDoc Technology (Beijing) Co. Ltd.
Not yet recruiting
https://ift.tt/2BbIq82